Detalles de la búsqueda
1.
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer.
Eur J Cancer;
199: 113555, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244363
2.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
J Clin Oncol;
42(3): 283-299, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864337
3.
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Cancer Cell;
40(12): 1537-1549.e12, 2022 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400018
4.
Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA Netw Open;
4(4): e214103, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33877311
5.
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.
J Pancreat Cancer;
7(1): 8-19, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33786412
6.
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
NPJ Breast Cancer;
5: 36, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667338
7.
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
BMC Cancer;
19(1): 578, 2019 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195996
8.
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Oncologist;
24(9): 1153-1158, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833486
9.
Comutation of PIK3CA and TP53 in Residual Disease After Preoperative Anti-HER2 Therapy in ERBB2 (HER2)-Amplified Early Breast Cancer.
JCO Precis Oncol;
3: 1-26, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100698
10.
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Lancet Oncol;
19(4): 497-509, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501363
11.
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Cancer Med;
7(6): 2288-2298, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29582557
12.
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
Am J Hematol;
92(5): 460-466, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28213943
13.
The Rise of Post-Grant Proceedings.
ACS Med Chem Lett;
8(1): 4-6, 2017 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28105262
14.
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
J Clin Oncol;
35(10): 1041-1048, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28113032
15.
Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer.
Clin Breast Cancer;
16(1): 31-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26433876
16.
Case Studies in the Management of Metastatic Breast Cancer with Eribulin.
Clin Med Insights Oncol;
9: 81-5, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26508896
17.
Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies.
Springerplus;
4: 532, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26413438
18.
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Clin Cancer Res;
21(19): 4305-11, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041745
19.
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.
Breast Cancer Res Treat;
146(2): 321-8, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24699910
20.
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
BMC Res Notes;
6: 507, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304724